How have KTTAW shares performed in 2024?

Pasithea Therapeutics' stock was trading at $0.0180 at the start of the year. Since then, KTTAW stock has decreased by 8.1% and is now trading at $0.0166. View the best growth stocks for 2024 here .

How do I buy shares of Pasithea Therapeutics?

Shares of KTTAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:KTTAW

Pasithea Therapeutics (KTTAW) Stock Price, News & Analysis

→ Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad)

Free KTTAW Stock Alerts

$0.02

0.00 (0.00%)

(As of 05/31/2024 ET)

Compare

Today's Range: $0.0166
▼
$0.0166
50-Day Range: $0.0122
▼
$0.0185
52-Week Range: $0.00
▼
$0.12

Volume: N/A
Average Volume: 10,113 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Short Interest Trends

Get Pasithea Therapeutics alerts:

Ad Wealthpin Pro

Are You Positioned For The New Energy Goldrush?

Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.

Click here to get all the information about it.

About Pasithea Therapeutics

Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.

KTTAW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

KTTAW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive KTTAW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:KTTAW
CUSIP: N/A
CIK: 1841330
Web: www.pasithea.com
Phone: 702-514-4174
Fax: N/A
Employees: 8
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $486,559.00
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Dr. Lawrence Steinman BA (Age 76)
M.D., Ph.D., Co-Founder, MD & Executive Chairman
Comp: $250k
Dr. Tiago Reis Marques M.D. (Age 46)
Ph.D., CEO & Director
Comp: $480k
Mr. Daniel H. Schneiderman (Age 46)
Chief Financial Officer
Comp: $345.94k
Dr. Graeme Currie Ph.D. (Age 57)
Chief Development Officer
Comp: $346.62k
Dr. Yassine Bendiabdallah Ph.D. (Age 40)
COO & Head of UK Clinics

Key Competitors

View All Competitors

KTTAW Stock Analysis - Frequently Asked Questions

How have KTTAW shares performed in 2024?: Pasithea Therapeutics' stock was trading at $0.0180 at the start of the year. Since then, KTTAW stock has decreased by 8.1% and is now trading at $0.0166.
View the best growth stocks for 2024 here.
How do I buy shares of Pasithea Therapeutics?: Shares of KTTAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:KTTAW) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial